TipRanks
Innovation1 Biotech (IVBT)
OTHER OTC:IVBT
US Market
IVBT
Innovation1 Biotech
RESEARCH TOOLSreports

Innovation1 Biotech (IVBT) Ratios

11 Followers

Innovation1 Biotech Ratios

IVBT's free cash flow for Q2 2024 was $0.00. For the 2024 fiscal year, IVBT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Aug 23Aug 22Aug 21Aug 20
Liquidity Ratios
Current Ratio
 0.02 0.02 <0.01 0.41 0.07
Quick Ratio
 0.02 0.02 0.01 0.37 0.06
Cash Ratio
 0.02 0.02 <0.01 0.34 <0.01
Solvency Ratio
 -1.69 -1.69 -0.93 2.56 -0.89
Operating Cash Flow Ratio
 -0.19 -0.19 -0.10 -0.07 -0.14
Short-Term Operating Cash Flow Coverage
 -62.02 -62.02 -312.79 -0.19 -0.49
Net Current Asset Value
$ -3.43M$ -3.43M$ -40.82M$ -238.25K$ -2.68M
Leverage Ratios
Debt-to-Assets Ratio
 3.01 3.01 0.01 0.88 4.03
Debt-to-Equity Ratio
 -0.07 -0.07 0.18 -0.71 -0.31
Debt-to-Capital Ratio
 -0.07 -0.07 0.15 -2.47 -0.46
Long-Term Debt-to-Capital Ratio
 -0.07 -0.07 0.00 0.00 0.00
Financial Leverage Ratio
 -0.02 -0.02 15.41 -0.81 -0.08
Debt Service Coverage Ratio
 -21.71 -21.71 -2.47K 3.32 -0.60
Interest Coverage Ratio
 -5.43 -5.43 -952.12 -1.17 -0.17
Debt to Market Cap
 50.96 0.01 <0.01 0.28 408.73
Interest Debt Per Share
 0.02 0.02 0.03 2.02 7.27
Net Debt to EBITDA
 -0.03 -0.03 >-0.01 0.02 -0.64
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%53.86%-150.97%
EBIT Margin
0.00%0.00%0.00%40909.09%-108636.75%
EBITDA Margin
0.00%0.00%0.00%40941.56%-108382.73%
Operating Profit Margin
0.00%0.00%0.00%-8390.94%-18374.26%
Pretax Profit Margin
0.00%0.00%0.00%33766.23%-218458.93%
Net Profit Margin
0.00%0.00%0.00%33766.23%-218458.93%
Continuous Operations Profit Margin
0.00%0.00%0.00%33766.23%-218458.93%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
438.04%438.04%778.63%-402.41%1188.94%
Return on Assets (ROA)
-7879.67%-7879.67%-92.98%571.79%-1236.80%
Return on Equity (ROE)
2074.16%174.58%-1433.02%-462.55%96.34%
Return on Capital Employed (ROCE)
42.57%42.57%-37.10%114.94%8.10%
Return on Invested Capital (ROIC)
42.71%42.71%-36.56%398.59%11.81%
Return on Tangible Assets
-8057.81%-8057.81%-4164.18%577.12%-1246.84%
Earnings Yield
-148335.32%-34.90%-1743.34%184.31%-125364.43%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 <0.01
Payables Turnover
 0.15 0.15 23.39 0.03 <0.01
Inventory Turnover
 0.00 0.00 -45.13 0.08 0.08
Fixed Asset Turnover
 0.00 0.00 0.00 5.15 0.59
Asset Turnover
 0.00 0.00 0.00 0.02 <0.01
Working Capital Turnover Ratio
 0.00 0.00 0.00 >-0.01 >-0.01
Cash Conversion Cycle
 -2.42K -2.42K -23.69 -6.39K -8.94K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 41.06K
Days of Inventory Outstanding
 0.00 0.00 -8.09 4.37K 4.61K
Days of Payables Outstanding
 2.42K 2.42K 15.61 10.76K 54.61K
Operating Cycle
 0.00 0.00 -8.09 4.37K 45.67K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 -0.21 -0.16 -1.40
Free Cash Flow Per Share
 -0.03 -0.03 -0.21 -0.16 -1.40
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -124.04K -124.04K -996.77 -0.18 0.00
Capital Expenditure Coverage Ratio
 -124.04K -124.04K -996.77 -6.08K 0.00
Operating Cash Flow Coverage Ratio
 -2.71 -2.71 -6.16 -0.19 -0.49
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 -9.87 -347.37
Free Cash Flow Yield
-13800.62%-3.61%-133.53%-5.39%-19934.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -2.87 -0.06 0.54 >-0.01
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 183.21 1.74
Price-to-Book (P/B) Ratio
 >-0.01 -5.00 0.82 -2.51 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -27.66 -0.75 -18.56 >-0.01
Price-to-Operating Cash Flow Ratio
 >-0.01 -27.66 -0.75 -18.56 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.04 <0.01 >-0.01 >-0.01
Price-to-Fair Value
 >-0.01 -5.00 0.82 -2.51 >-0.01
Enterprise Value Multiple
 -0.03 -3.05 -0.07 0.47 -0.64
Enterprise Value
 183.64K 17.34M 2.70M 586.81K 825.35K
EV to EBITDA
 -0.03 -3.05 -0.07 0.47 -0.64
EV to Sales
 0.00 0.00 0.00 190.52 698.85
EV to Free Cash Flow
 -0.30 -27.95 -0.86 -19.30 -2.01
EV to Operating Cash Flow
 -0.30 -27.95 -0.86 -19.30 -2.01
Tangible Book Value Per Share
 -0.17 -0.17 -2.64 -1.20 -9.11
Shareholders’ Equity Per Share
 -0.17 -0.17 0.19 -1.20 -9.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.02 <0.01
Net Income Per Share
 -0.30 -0.30 -2.68 5.53 -8.78
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.04 1.04 1.00 0.83 2.01
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 77.91 179.87
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.10 0.10 0.08 -0.03 0.16
Currency in USD